Ultragenyx Pharmaceutical Inc (RARE)
43.27
+0.74
(+1.74%)
USD |
NASDAQ |
May 01, 16:00
43.27
0.00 (0.00%)
After-Hours: 20:00
Ultragenyx Pharmaceutical Total Return Level: 42.53 for April 30, 2024
Total Return Level Chart
Historical Total Return Level Data
Date | Value |
---|---|
April 30, 2024 | 42.53 |
April 29, 2024 | 44.02 |
April 26, 2024 | 44.24 |
April 25, 2024 | 43.85 |
April 24, 2024 | 44.28 |
April 23, 2024 | 45.11 |
April 22, 2024 | 43.69 |
April 19, 2024 | 42.37 |
April 18, 2024 | 43.38 |
April 17, 2024 | 44.11 |
April 16, 2024 | 42.31 |
April 15, 2024 | 42.87 |
April 12, 2024 | 47.00 |
April 11, 2024 | 50.70 |
April 10, 2024 | 51.61 |
April 09, 2024 | 50.56 |
April 08, 2024 | 50.23 |
April 05, 2024 | 50.24 |
April 04, 2024 | 47.08 |
April 03, 2024 | 47.08 |
April 02, 2024 | 46.59 |
April 01, 2024 | 46.97 |
March 28, 2024 | 46.69 |
March 27, 2024 | 46.82 |
March 26, 2024 | 45.46 |
Date | Value |
---|---|
March 25, 2024 | 45.42 |
March 22, 2024 | 45.85 |
March 21, 2024 | 46.65 |
March 20, 2024 | 47.01 |
March 19, 2024 | 47.00 |
March 18, 2024 | 46.59 |
March 15, 2024 | 47.37 |
March 14, 2024 | 46.65 |
March 13, 2024 | 48.55 |
March 12, 2024 | 47.66 |
March 11, 2024 | 48.51 |
March 08, 2024 | 50.53 |
March 07, 2024 | 50.85 |
March 06, 2024 | 51.26 |
March 05, 2024 | 51.47 |
March 04, 2024 | 53.31 |
March 01, 2024 | 53.69 |
February 29, 2024 | 51.72 |
February 28, 2024 | 52.75 |
February 27, 2024 | 53.66 |
February 26, 2024 | 50.25 |
February 23, 2024 | 49.48 |
February 22, 2024 | 48.88 |
February 21, 2024 | 48.18 |
February 20, 2024 | 47.87 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
31.73
Minimum
Oct 18 2023
177.39
Maximum
Dec 23 2020
65.98
Average
57.04
Median
Total Return Level Benchmarks
Corcept Therapeutics Inc | 23.33 |
Madrigal Pharmaceuticals Inc | 204.02 |
Sarepta Therapeutics Inc | 126.56 |
FibroGen Inc | 1.12 |
Rocket Pharmaceuticals Inc | 21.55 |